Journal of Drugs in Dermatology

J Drugs Dermatol

1545-9616

Therapeutic Area

Aesthetics Medicine, Cosmetic Sciences, Dermatology, Research

Aestheticians, Allied Health Professionals, Cosmetologists, Dermatologists, Nurse Practitioners, Physician Assistants, Researchers, Residents, Scientists - Research/Biomedical Aging

The Journal of Drugs in Dermatology (JDD) is a peer-reviewed publication indexed with MEDLINE®/PubMed®, founded by Dr. Perry Robins MD in 2002. It offers one of the fastest routes for disseminating dermatologic information and is considered the fastest-growing publication in dermatology. JDD publishes original articles, award-winning case reports, and timely features on new methods, techniques, drug therapy, and devices in dermatology, providing readers with peer-reviewed content of the highest quality. High standards of content are maintained through a balanced peer-review process, with articles reviewed by an International Editorial Board of over 160 renowned experts. JDD reaches approximately 13,760 dermatology healthcare professionals and is recognized as the official partner of the Skin of Color Update (SOCU) and the ODAC Dermatology Aesthetic and Surgical (ODAC) conferences. Its current and practical editorial content ensures high readership and maximum exposure within the dermatology community. The mission is excellence through peer review: to educate physicians, optimize patient outcomes, and disseminate key scientific information.

International Society for Dermatologic Surgery (ISDS)

SanovaWorks

Impact Factor JCR Categories/Rank Circulation Electronic Circulation Submission to Acceptance Acceptance to Print Publication Rejection Rate Frequency Journal Contact Author Submission Guidelines